Nos publications

Mise à jour novembre 2023

Title Authors Year Journal Link to Article Intended Audience Purpose
CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fc? Receptor– and Complement Receptor 3–Dependent Mechanisms Amash A, Wang L, Wang Y, Bhakta V, Fairn GD, Hou M, Peng J, Sheffield WP, Lazarus AH 2016 J Immunol View Researchers Basic research
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcgammaRIIb genetic disruption Crow AR, Amash A, Lazarus AH 2014 Transfusion View Researchers Basic research
CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia Qiu J, Liu X, Li X, Zhang X, Han P, Zhou H, Shao L, Hou Y, Min Y, Kong Z, Wang Y, Wei Y, Liu X, Ni H, Peng J, Hou M 2016 Sci Rep View Researchers Basic research
CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, Shi Y, Yougbaré I, Wang X, Zhu G, Chen P, Prudhomme GJ, Lazarus AH, Freedman J, Ni H 2015 Blood View Researchers Basic research
Cell-based therapy using umbilical cord blood for novel indications in regenerative therapy and immune modulation: an updated systematic scoping review of the literature Rizk M, Aziz J, Shorr R, Allan DS 2017 Biol Blood Marrow Transplant View Researchers Clinical research
Cell-matrix interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules Sayyar B, Dodd M, Marquez-Curtis L, Janowska-Wieczorek A, Hortelano G 2014 Artif Cells Nanomed Biotechnol View Researchers Basic research
Cellular immune dysfunction in immune thrombocytopenia (ITP) McKenzie CGJ, Guo L, Freedman J, Semple JW 2013 Br J Haematol View Researchers Basic research
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM 2018 J Thromb Haemost View Researchers Clinical research
Centre d’innovation Rapport d’étape annuel 2019-2020 Levy I, Pambrun C 2020 Blood.ca website Other Other
Centre for Innovation Annual Progress Report 2019-2020 Levy I, Pambrun C 2020 Blood.ca website Other Other
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty Hwang SR, Wang Y, Weil EL, Padmanabhan A, Warkentin TE, Pruthi RK 2020 Platelets View Health care providers Clinical research
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company Hay CRM, Shima M, Makris M, Jiménez-Yuste V, Oldenburg J, Fischer K, Iorio A, Skinner MW, Santagostino E, von Mackensen S, Kessler CM 2020 Haemophilia View Researchers Clinical research
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies Warkentin TE 2020 Hämostaseologie View Health care providers Clinical research
Challenges in the management of the blood supply Williamson LM, Devine DV 2013 Lancet View Blood operators Other
Challenging the 30-min rule for thawed plasma Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W 2021 Vox Sang View Researchers Benchmarking and standard setting
Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study Yazer MH, Jackson B, Beckman N, Chesneau S, Bowler P, Delaney M, Devine D, Field S, Germain M, Murphy MF, Sayers M, Shaz B, Shinar E, Takanashi M, Vassallo R, Wickenden C, Yahalom V, Land K, on behalf of the BEST Collaborative 2016 Transfusion View Blood operators New or improved product or process
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C 2012 Transfusion View Health care providers New or improved product or process
Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency Goldman M, Yi Q-L, Steed T, O'Brien SF 2019 Transfusion View Researchers New or improved product or process
Changes in plasma unit distributions to hospitals over a 10-year period Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH 2018 Transfusion View Blood operators Clinical research
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era Reedman CN, Drews SJ, Yi Q-L, Pambrun C, O’Brien SF 2022 Microbiol Spectr View Researchers Clinical research
Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells Ramirez-Arcos S, Kou Y, Ducas É, Thibault L 2016 Transfus Med Hemother View Blood operators Benchmarking and standard setting
Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk Davison KL, Gregoire Y, Germain M, Custer B, O'Brien SF, Steele WR, Pillonel J, Seed CR 2019 Vox Sang View Blood operators New or improved product or process
Changing trends in blood transfusion: an analysis of 244,013 hospitalizations Shehata N, Forster A, Lawrence N, Rothwell DM, Fergusson D, Tinmouth A, Wilson K 2014 Transfusion View Health care providers Clinical research
Chapitre 10. Les réactions transfusionnelles Laureano M, Khandelwal A, Yan M 2022 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 14. Aphérèse thérapeutique Oliver M, Patriquin C 2023 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss Prokopchuk-Gauk O, Solh Z 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes Blais-Normandin I, Tordon B, Anani W, Ning S 2022 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 2: Les composants sanguins Gupta A, Bigham M 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire Poon MC, Goodyear D, Rydz N, Lee A 2022 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes Drews S, Khandelwal A, Goldman M, Devine D 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapter 10. Transfusion reactions Laureano M, Khandelwal A, Yan M 2022 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 11: Massive hemorrhage and emergency transfusion Trudeau J, Dawe P, Shih A 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 14. Therapeutic apheresis Oliver M, Patriquin C 2023 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 16: Preoperative autologous donation Foster T, Yan M 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 17. Hemostatic disorders and hereditary angioedema Poon MC, Goodyear D, Rydz N, Lee A 2022 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 17. Troubles de l’hémostase et angiœdème héréditaire Poon MC, Goodyear D, Rydz N, Lee A 2022 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Chapter 19. Pathogen-reduced platelets Blais-Normandin I, Tordon B, Anani W, Ning S 2022 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 2. Blood components Gupta A, Bigham M 2023 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 2: Blood components Gupta A, Bigham M 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 33: Synthesis of N-(4-Methoxybenzyl)-2-(α-d-glucopyranosyl) acetamide Roy R, Vidal S, Briard JG, Shiao TC, Ben RN 2015 Carbohydrate Chemistry: Proven Synthetic Methods, Volume 3 View Researchers Basic research
Chapter 4: Clinical transfusion procedures Clarke G, Al-Riyami AZ, Roxby D 2021 Educational Modules on Clinical Use of Blood View Health care providers Benchmarking and standard setting
Chapter 5 - Platelet microRNAs Provost P 2013 Platelets (Third Edition) View Researchers Other
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema Poon MC, Goodyear D, Rydz N, Lee A 2022 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chapter 6: Donor selection, donor testing and pathogen reduction Drews S, Khandelwal A, Goldman M, Devine D 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Chaptire 16: Don autologue préopératoire Foster T, Yan M 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects Huynh A, Arnold DM, Smith JW, Moore JC, Zhang A, Chagla Z, Harvey BJ, Stacey HD, Ang JC, Clare R, Ivetic N, Chetty VT, Bowdish DME, Miller MS, Kelton JG, Nazy I 2021 Viruses View Researchers Clinical research
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I 2023 Blood Adv View Researchers Clinical research
Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris de Bold MK, Sheffield WP, Martinuk A, Bhakta V, Eltringham-Smith L, de Bold AJ 2012 Regul Pept View Researchers Basic research
Characterization of CD41(+) cells in the lymph node Dai L, Uehara M, Li X, LaBarre BA, Banouni N, Ichimura T, Lee-Sundlov MM, Kasinath V, Sullivan JA, Ni H, Barone F, Giannini S, Bahmani B, Sage PT, Patsopoulos NA, Tsokos GC, Bromberg JS, Hoffmeister K, Jiang L, Abdi R 2022 Front Immunol View Researchers Basic research
Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I 2018 J Thromb Haemost View Researchers Basic research